Axogen (AXGN) vs UFP Technologies (UFPT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Axogen (AXGN) has outperformed UFP Technologies (UFPT) over the past year, gaining 110.8% versus a gain of 45.9%. Over five years, UFPT leads with a +358.9% price change compared with +164.6% for AXGN. UFP Technologies is the larger company by market cap ($2.22 billion vs $2.12 billion), about 1.0 times the size.
On valuation, UFP Technologies trades at a lower forward P/E (24.1x vs 52.6x for Axogen).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AXGN | UFPT |
|---|---|---|
| Share price | $36.18 | $286.56 |
| Market cap | $2.12B | $2.22B |
| 1-day change | +0.39% | -2.15% |
| YTD return | +10.54% | +29.06% |
| 1-year return | +110.84% | +45.90% |
| 5-year return | +164.61% | +358.90% |
| P/E ratio (TTM) | — | 30.95 |
| Forward P/E | 52.59 | 24.14 |
| EPS (TTM) | $-0.67 | $9.26 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $52.91 | $338.71 |
| 52-week low | $15.27 | $173.86 |
| Distance from 52-week high | -31.62% | -15.40% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +48.76% | +23.88% |
| Average volume | 1.22M | 154.12K |
| Shares outstanding | 58.67M | 7.75M |
| Employees | 622 | 4,846 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- AXGN has outperformed UFPT by 64.9 percentage points over the past year.
About Axogen
AXGN stock →Axogen, Inc., together with its subsidiaries, engages in the development and commercialization of the technologies used for peripheral nerve regeneration and repair worldwide. The company offers Avance Nerve Graft, a processed nerve allograft intended for the surgical repair of peripheral nerve discontinuities; Axoguard Nerve Connector, a coaptation aid used to align and connect severed peripheral nerve ends in a tensionless repair; and Axoguard Nerve Protector, a product used to protect and wrap damaged peripheral nerves and reinforce reconstructed nerve gaps.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 622 employees
About UFP Technologies
UFPT stock →UFP Technologies, Inc., together with its subsidiaries, designs and manufactures solutions for medical devices, sterile packaging, and other engineered custom products in the United States. The company provides protective drapes for robotic surgery, patient handling and comfort, advanced wound care, infection prevention, disposables for surgical and endoscopic procedures, packaging for medical devices, orthopedic implants, components for cardiac implants, dispenser coils for catheters, and biopharma drug manufacturing.
Health Care · Medical/Dental Instruments · 4,846 employees
AXGN vs UFPT FAQ
Which is bigger, Axogen or UFP Technologies?
UFP Technologies (UFPT) is larger, with a market capitalization of $2.22B compared with $2.12B for Axogen (AXGN).
Which stock has performed better over the past year, AXGN or UFPT?
AXGN returned +110.84% over the past 12 months, compared with +45.90% for UFPT (price return, excluding dividends). Past performance does not predict future results.
Are Axogen and UFP Technologies in the same industry?
Both are in the Health Care sector, but in different industries: Biotechnology: Electromedical & Electrotherapeutic Apparatus for Axogen and Medical/Dental Instruments for UFP Technologies.